Veradermics (MANE) Current Assets (2024 - 2026)
Veradermics (MANE) posted Current Assets of $397.1 million for Q1 2026, up 160.38% on a QoQ basis from $152.5 million in Q4 2025.
Veradermics (MANE) Current Assets (2024 - 2026) Analysis & Trends
Veradermics' Current Assets history runs 3 years deep, the most recent figure standing at $397.1 million for Q1 2026.
- Quarterly Current Assets changed N/A year-over-year to $397.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $397.1 million (changed N/A YoY) and the FY2025 annual result came in at $152.5 million, up 174.59% from the prior year.
- Current Assets was $397.1 million for Q1 2026 at Veradermics, up from $152.5 million in the prior quarter.
- Across five years, Current Assets topped out at $397.1 million in Q1 2026 and bottomed at $55.5 million in Q4 2024.
- A 3-year average of $201.7 million and a median of $152.5 million in 2025 frame the typical range for Current Assets.
- Peak annual rise in Current Assets reached 174.59% in 2025, while the deepest fall reached 174.59% in 2025.
- Veradermics' Current Assets stood at $55.5 million in 2024, then surged by 174.59% to $152.5 million in 2025, then surged by 160.38% to $397.1 million in 2026.
- Business Quant data shows MANE's Current Assets at $397.1 million in Q1 2026, $152.5 million in Q4 2025, and $55.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Veradermics | 2.63 Bn | 2.63 Bn | - | 397.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 397.07 Mn |
| Dec 31, 2025 | 152.49 Mn |
| Dec 31, 2024 | 55.54 Mn |